Koyfin Home > Directory > Health Care > Kura Oncology > Cash Flow from Operations

Kura Oncology Cash Flow from Operations Chart (KURA)

Kura Oncology annual/quarterly Cash Flow from Operations from 2014 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Kura Oncology Cash Flow from Operations for the quarter ending June 06, 2020 was $-15m a 17.57% decrease of -3m year over year
  • Kura Oncology Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-61m a 15.83% decrease of -10m year over year
  • Kura Oncology Annual Cash Flow from Operations for 2019 was $-55m a 11.15% decrease of -6m from 2018
  • Kura Oncology Annual Cash Flow from Operations for 2018 was $-49m a 41.55% decrease of -20m from 2017
  • Kura Oncology Annual Cash Flow from Operations for 2017 was $-28m a 10.87% decrease of -3m from 2016
Other Cash Flow Metrics:
  • Kura Oncology Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-13m a 43.33% decrease of -6m year over year
View Chart On Koyfin

Quarterly KURA Cash Flow from Operations Data

06/2020$-15m
03/2020$-20m
12/2019$-14m
09/2019$-12m
06/2019$-14m
03/2019$-14m
12/2018$-10m
09/2018$-13m
06/2018$-13m
03/2018$-13m

Annual KURA Cash Flow from Operations Data

2019$-55m
2018$-49m
2017$-28m
2016$-25m
2015$-18m
2014$-3m